Literature DB >> 176177

Effect of adenosine deaminase inhibition upon human lymphocyte blastogenesis.

D A Carson, J E Seegmiller.   

Abstract

The biochemical mechanisms by which a genetically determined deficiency of adenosine deaminase leads to immunodeficiency are still poorly understood and prompted this study. We have examined the effects of the adenosine deaminase inhibitor erythro-9-(2-hydroxy-3-nonyl) adenine hydrochloride (EHNA) upon the response of human peripheral blood mononuclear cells to the mitogen concanavalin A (Con A). Cells isolated from normal volunteers were incubated in microtiter plates in the presence of various inhibitors, and the incorporation of tritrated thymidine or leucine into macromolecular material was measured after 64 h. EHNA at a concentration of 0.3 muM, which inhibited 90% of the adenosine deaminase (ADA) activity in a mononuclear preparation, impaired the incorporation of tritrated leucine into protein; 100 muM EHNA was the minimal concentration that inhibited thymidine uptake. The addition of 15 muM adenosine or 10 muM cyclic AMP to Con A-stimulated lymphocytes inhibited leucine uptake, while millimolar concentrations were required to inhibit thymidine uptake. Lower doses of adenosine and cyclic AMP stimulated thymidine incorporation. The inhibition of thymidine uptake observed with millimolar concentrations of adenosine was independent of the type of mitogen (pokeweed or Con A), the concentration of mitogen, or the medium used, but could be increased if the cells were cultured in a serum with reduced levels of adenosine deaminase. Washout experiments failed to demonstrate a critical period early in immune induction during which adenosine exerted its inhibitory effects. Noninhibitory doses of EHNA potentiated the effects of adenosine and cyclic AMP on leucine and thymidine uptake. EHNA at a concentration of 50 muM also potentiated the inhibitory effects on thymidine uptake of dibutyryl cyclic AMP, butyric acid, norepinephrine, and isoproterenol, but not theophylline. When mitogenesis was assayed by leucine incorporations, no synergy between EHNA and these compounds was apparent. Uridine relieved to some extent the inhibition of blastogenesis produced by adenosine and cyclic AMP, but not by dibutyryl cyclic AMP, norepinephreine, isoproterenol, or theophylline. Neither uridine alone nor uridine plus adenosine protected lymphocytes from the inhibitory effects of EHNA.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 176177      PMCID: PMC436651          DOI: 10.1172/JCI108278

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

1.  Adenosine inhibition of lymphocyte-mediated cytolysis: possible role of cyclic adenosine monophosphate.

Authors:  G Wolberg; T P Zimmerman; K Hiemstra; M Winston; L C Chu
Journal:  Science       Date:  1975-03-14       Impact factor: 47.728

2.  Mutants of chinese hamster cells resistant to adenosine.

Authors:  M W McBurney; G F Whimore
Journal:  J Cell Physiol       Date:  1975-02       Impact factor: 6.384

3.  The effect of adenosine and adenine nucleotides on the cyclic adenosine 3', 5'-phosphate content of guinea pig cerebral cortex slices.

Authors:  A Sattin; T W Rall
Journal:  Mol Pharmacol       Date:  1970-01       Impact factor: 4.436

4.  Divergent action mechanism of cAMP and dibutyryl cAMP on cell proliferation and macromolecular synthesis in HeLa S3 cultures.

Authors:  H Hilz; E Kaukel
Journal:  Mol Cell Biochem       Date:  1973-06-27       Impact factor: 3.396

5.  Divergent action of cAMP and dibutyryl cAMP on macromolecular synthesis in HeLa S3 cultures.

Authors:  E Kaukel; U Fuhrmann; H Hilz
Journal:  Biochem Biophys Res Commun       Date:  1972-09-26       Impact factor: 3.575

6.  Lymphocyte blast transformation. I. Demonstration of adrenergic receptors in human peripheral lymphocytes.

Authors:  J W Hadden; E M Hadden; E Middleton
Journal:  Cell Immunol       Date:  1970-12       Impact factor: 4.868

7.  Effect of cyclic 3',5'-adenosine monophosphate and theophylline on lymphocyte transformation.

Authors:  R Hirschhorn; J Grossman; G Weissmann
Journal:  Proc Soc Exp Biol Med       Date:  1970-04

8.  Adenosine-deaminase deficiency and combined immunodeficiency syndrome.

Authors:  J Dissing; B Knudsen
Journal:  Lancet       Date:  1972-12-16       Impact factor: 79.321

9.  Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity.

Authors:  E R Giblett; J E Anderson; F Cohen; B Pollara; H J Meuwissen
Journal:  Lancet       Date:  1972-11-18       Impact factor: 79.321

10.  Human lymphocytic metabolism. Effects of cyclic and noncyclic nucleotides on stimulation by phytohemagglutinin.

Authors:  J W Smith; A L Steiner; C W Parker
Journal:  J Clin Invest       Date:  1971-02       Impact factor: 14.808

View more
  31 in total

1.  Adenosine deaminase activity in thymus and other human tissues.

Authors:  A Adams; R A Harkness
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

2.  Structural differences between plasma-membrane 5'-nucleotidase in different cell types as evidenced by antibodies.

Authors:  J Harb; K Meflah; S Bernard
Journal:  Biochem J       Date:  1985-12-15       Impact factor: 3.857

3.  Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: possible role of nucleoside kinase(s).

Authors:  D A Carson; J Kaye; J E Seegmiller
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

4.  Repeated pentostatin (2'deoxycoformycin)-induced remissions in a patient with advanced chronic lymphocytic leukemia.

Authors:  R O Dillman; A L Yu; C N Qiao
Journal:  West J Med       Date:  1988-03

Review 5.  Combined immunodeficiency and inborn errors of purine metabolism.

Authors:  H J Meuwissen; B Pollara
Journal:  Blut       Date:  1978-10-13

Review 6.  Adenosine and adenosine receptors in immune function. Minireview and meeting report.

Authors:  R B Gilbertsen
Journal:  Agents Actions       Date:  1987-10

7.  Purine excretion by mouse peritoneal macrophages lacking adenosine deaminase activity.

Authors:  T S Chan
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

8.  Mammalian ribonucleotide reductase subunit p53R2 is required for mitochondrial DNA replication and DNA repair in quiescent cells.

Authors:  Giovanna Pontarin; Paola Ferraro; Leonardo Bee; Peter Reichard; Vera Bianchi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-30       Impact factor: 11.205

9.  Action of deoxycoformycin on human T cell colonies in vitro.

Authors:  N R Colledge; A S Krajewski; J F Smyth; A H Wyllie
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

10.  In vitro of adenosine on lymphocytes and erythrocytes from horses with combined immunodeficiency.

Authors:  N S Magnuson; L E Perryman
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.